Significance of toll-like receptors expression in tumor growth and spreading: a short review.
Toll-like receptors (TLRs) are considered now as crucial sensors of innate immunity. Their role in the recognition of pathogens and the initiation of adaptive immune responses against them is well known. However, in last years TLRs have been identified on several tumor cells, including human malignancies. Their expression in cancer was found to be twofold: either promoting or inhibiting tumor progression. It was also demonstrated that several TLRs agonists, either natural or synthetic ones, may have beneficial effect on tumor-mediated disease, leading to potentiation of immune response to tumor-associated antigens. TLR-agonist linked tumor immunotherapy is still in nascent state, but growing rapidly, also in the area of common human malignancies. To date, the most promising and the most frequently studied interaction in tumor immunotherapy trials seems to be TLR9 and its synthetic agonists.
Zeromski
Jan
J
Clinical Immunology, Medical University, Rokietnicka 5D, Poznan, Poland. jzeromski@ump.edu.pl
Mozer-Lisewska
Iwona
I
Kaczmarek
Mariusz
M